Search

everythinglearnresearchcommunity

for

Search:↓

A man with Acrodermatitis continua did not get better with etanercept treatment, and his condition worsened, suggesting treatment effectiveness may vary by genetics and race.

A protein called ectodysplasin-A2 increases a hair growth inhibitor in balding cells, which could be a target for hair loss treatment.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

CLEC4D gene variants may increase the risk of alopecia areata in Jordanians.

KAP8.1 protein is crucial for hair structure and interacts with keratin 85.

A protein from fat-derived stem cells, DKK1, is linked to hair loss and blocking it may help treat alopecia areata.

A circulating inhibitor caused insulin resistance, but clomiphene improved symptoms.

These specific gene polymorphisms are not linked to Alopecia Areata in Egyptians.

Men with a certain type of hair loss (vertex type AGA) may have higher levels of bad fats (triglycerides) and lower levels of good cholesterol (HDL), suggesting they could be at risk for high fat levels in the blood (hyperlipidemia).

PP405 shows promise as a new, effective treatment for hair loss with minimal side effects.

A peptide from hair follicle stem cells promotes hair growth by activating specific skin cells.

A reliable method was developed to measure aristolochic acid-I in rat blood.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

NXC736 significantly reduced hair loss in mice with alopecia areata.

The AMHR2-482A>G gene change is linked to higher PCOS risk.

Epigenetic changes in blood cells may contribute to alopecia areata.

Most patients improved in both atopic dermatitis and alopecia areata with certain treatments, but some had worsened symptoms, suggesting personalized care is needed.

Apremilast helps regrow hair in hard-to-treat alopecia areata.

Women with AGA have higher lipid levels, increasing heart disease risk.

ODC1 gene mutations cause a neurodevelopmental disorder with large head size, hair loss, and facial abnormalities.

A boy with GAPO syndrome had hair loss similar to male pattern baldness without hormone issues, possibly due to skin or blood vessel problems.

New treatments for alopecia areata show promise but need ongoing use and have infection risks.

ALEP is a drug-triggered skin reaction with pustules that clears up in a week after stopping the drug.

Male hormones and reduced plakoglobin can impair heart electrical function and increase arrhythmia risk in males.

New ABCA12 gene mutations were linked to a skin condition with scaling and hair loss, and a treatment helped with hair loss in a related case.

PRP injections significantly improve hair regrowth in alopecia areata.

Polydopamine is promising for personalized medicine and biomedical technology due to its strong adhesion and biocompatibility.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

The KRTAP21-1 gene affects wool yield and can help improve wool production.